Thalidomide as a drug may still have some use in the treatment of some cancers and several inflammatory conditions. It is used as a cure for leprosy along with myeloma. There is no doubt that prescription drugs make a significant difference in the daily lives of many people. These types of drug treatments go through quite significant testing and safety protocols before they are offered for prescription. A few medicines pass the multi-fluctuation evaluation, after which they are discontinued by the pharmaceutical business. The high level required for drugs to be approved for the market came about as a result of stricter standards due to previous problems, some of which were quite spectacular. The thalidomide debacle became by far the most recognized of these problems.
Thalidomide was originally distributed in 1957 in West Germany to treat anxiety, sleep problems and morning sickness in pregnancy. Thalidomide became quite effective for morning sickness in pregnancy and was quickly approved in 46 countries worldwide for use by women who were currently pregnant. It was not licensed for use and distribution in the US, where it was rejected by the Federal Drug Administration for not meeting high enough criteria. Thalidomide has never been tested to see if it is safe during pregnancy. The end result of its use in pregnancy is estimated to have resulted in more than 10,000 births with a number of severe deformities and many miscarriages. Of the live births, slightly more than half died within weeks of birth. This may be the most significant controversy in the history of the drug field.
The downsides of thalidomide were initially recognized in 1961 by an Australian physician, William McBride, who then sent a letter to the medical journal Lancet regarding his findings of an increase in malformed babies born at his hospital of which the mothers used the drug. Around the same time, the pediatrician Widukind Len z also noted many similar cases in Germany, where the drug was still sold freely, not only by prescription. This prompted an investigation and subsequent ban on the sale of thalidomide. In 1968, the West German firm that produced the drug, Che MIE GRU NEN THA l GmbH, was taken to court in West Germany, with the company settling the case out of court and no litigation continuing. Thanks to this, German victims were compensated. No one from the company has been found guilty of any criminal activity. In the United Kingdom, victims of the drug also ended up being compensated by British distributors of thalidomide. In other countries, there have been several class action lawsuits that have resulted in payouts many years after the drugs were discontinued.
The current press involving this and the birth problems that have occurred as a result of thalidomide cast a dark shadow over the entire pharmaceutical sector. The resulting conviction ended up formulating much better programs for drug regulation and also drug approval oversight in every single country. This was particularly the case with the use of drugs during pregnancy, where the standards and assumptions were greatly increased.
You must be logged in to post a comment.